|
||||||||||||||||||
 |
From: TSS ()
In Reply to: RE- FDA FORMS TASK FORCE ON HUMAN TISSUE SAFETY posted by TSS on September 1, 2006 at 9:54 pm:
Q: Are there any other competitors that offers anything similar to your technology? A: There's one company (that) certainly has a process that seems to work well. They're called Regeneration Technologies Inc., in Florida. It's a different process entirely from ours, but based on claims they've made and presentations of data, it seems that it also eliminates the risk of bacteria from those tissue implants. Now we've never seen data from Regeneration Technologies about elimination of viruses, so I can't comment on their technology regarding virus inactivation. In our case, we do eliminate both bacteria and viruses, such as HIV, hepatitis B, hepatitis C, West Nile virus and other viruses.
A: No. Unfortunately, we don't eliminate the risk of prion or CJD transmission.
A: Basically, expanding the amount of direct distribution that we're doing. I think the environment is very receptive. Recent events continue to just make surgeons more aware that having a method that sterilizes very broadly against any kind of infectious disease being transmitted while maintaining fully the performance integrity of the tissue is highly desirable. We just started launching this direct distribution program in July of this year and we're already planning to expand it.
please see link below
|
